香港联交所最新数据显示，11月24日，非执行董事郭华清增持科济药业(02171)3万股，每股作价16.39港 元，总金额为49.17万港元。增持后最新持股数目约为2.18亿股，持股比例为37.75%。 ...

Summary of Key Points Core Viewpoint - A total of 36 companies conducted share buybacks on November 24, 2025, with Tencent Holdings (00700) leading in both the number of shares repurchased and the total amount spent on buybacks. Group 1: Buyback Details - Tencent Holdings (00700) repurchased 1.022 million shares for a total of 636 million yuan, representing 0.825% of its total share capital for the year [1][2]. - China COSCO Shipping (01919) repurchased 3 million shares for 40.35 million yuan, accounting for 1.604% of its total share capital [2]. - China International Marine Containers (02039) repurchased 4.8904 million shares for 35.9467 million yuan, which is 1.530% of its total share capital [2]. Group 2: Other Notable Buybacks - China Feihe (06186) repurchased 7.233 million shares for 29.9668 million yuan, representing 1.969% of its total share capital [2]. - Sinopec Limited (00386) repurchased 4.054 million shares for 17.7861 million yuan, which is 0.150% of its total share capital [2]. - Pacific Basin Shipping (02343) repurchased 5 million shares for 12.757 million yuan, accounting for 1.555% of its total share capital [2]. Group 3: Smaller Buybacks - MONGOL MINING (00975) repurchased 390,000 shares for 3.6551 million yuan, which is 0.124% of its total share capital [2]. - Miniso Group (09896) repurchased 866,800 shares for 31.938 million yuan, representing 0.372% of its total share capital [2]. - Weigao Group (01066) repurchased 40,000 shares for 211,600 yuan, accounting for 4.379% of its total share capital [3].

Summary of Key Points Core Viewpoint - The company Kintor Pharmaceutical Co., Ltd. has been actively repurchasing its shares, indicating a strategy to support its stock price amid recent declines [2][3]. Group 1: Share Buyback Activity - On November 24, Kintor repurchased 360,000 shares at a price range of HKD 15.880 to HKD 16.750, totaling HKD 5.9567 million [2]. - The stock closed at HKD 15.880 on the same day, reflecting a decline of 6.15%, with a total trading volume of HKD 103 million [2]. - Since November 20, the company has conducted share buybacks for three consecutive days, accumulating a total of 763,000 shares repurchased and a total expenditure of HKD 12.914 million, during which the stock price fell by 8.26% [2]. Group 2: Year-to-Date Buyback Summary - Year-to-date, Kintor has executed nine buyback transactions, repurchasing a total of 4.1855 million shares for a cumulative amount of HKD 66.6845 million [3]. - The detailed buyback transactions include various dates, share quantities, and price ranges, showcasing a consistent effort to stabilize the stock price [3].

科济药业-B(02171)发布公告，于2025年11月24日斥资595.67万港元回购36万股。 ...

Group 1 - The company Kintor Pharmaceutical-B (02171.HK) announced a share buyback on November 24, spending HKD 5.957 million to repurchase 360,000 shares [1]

智通财经APP讯，科济药业-B(02171)发布公告，于2025年11月24日斥资595.67万港元回购36万股。 ...

表格類別： 股票 狀態： 新提交 公司名稱： 科濟藥業控股有限公司 呈交日期： 2025年11月24日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02171 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | 庫存股份變動 | 每股發行/出售價 (註4) | 已發行股份總數 | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | | | | ...

Group 1 - The core point of the article is that Kexing Pharmaceutical-B has been actively repurchasing its shares, with a total of 382.55 million shares repurchased this year, amounting to 607.28 million HKD [2][3] - On November 21, the company repurchased 235,000 shares at a price range of 16.570 to 17.090 HKD, totaling 3.9829 million HKD, while the stock closed at 16.920 HKD, down 4.14% for the day [2] - Since November 20, the company has conducted share buybacks for two consecutive days, repurchasing a total of 403,000 shares for a cumulative amount of 6.9572 million HKD, during which the stock price has decreased by 2.25% [2][3] Group 2 - The detailed buyback history shows that on November 20, 168,000 shares were repurchased at a maximum price of 17.850 HKD and a minimum price of 17.540 HKD, totaling 2.9744 million HKD [3] - The largest buyback occurred on November 6, with 1.734 million shares repurchased at a maximum price of 15.800 HKD, totaling 26.3078 million HKD [3] - The buyback activity indicates a strategic move by the company to support its stock price amid recent declines [2][3]

Group 1 - The company Kintor Pharmaceutical (02171) announced a share buyback plan, committing to repurchase 235,000 shares at a total cost of HKD 3.9829 million [1]

科济药业-B(02171)发布公告，于2025年11月21日，该公司斥资398.29万港元回购23.5万股。 ...